Vitamin K metabolism and activation of dependent proteins (WP5186)

Homo sapiens

Vitamin K is recycled in the liver in order to maintain sufficient levels for activating vitamin K-dependent proteins (VKDP), including certain coagulation factors. In this process, vitamin K1 (taken up from the diet) is converted to vitamin K hydroquinone (KH2), either by the dithiol-dependent vitamin K-epoxide reductase (VKOR) or by NAD(P)H dehydrogenase quinone 1. KH2 is in turn oxidized to vitamin K epoxide (KO) by the enzyme gamma-glutamyl carboxylase (GGCX). During this conversion, GGCX activates the VKDPs by converting glutamate (Glu) to gamma-carboxyglutamate (Gla). Lastly, KO is converted back into vitamin K quinone by VKOR. Warfarin, a drug commonly used as a anticoagulant, inhibits VKOR, thus reducing the levels of VKH2 in the bloodstream. A too high dosage of warfarin can lead to heavy bleeding, a life-threatening condition. Threatment of this condition is a high dosis of Vitamine K, which is reduced to VHK2 by FSP1, a warfarin resistant reductase. The influence of FSP1 on this process, as well as its potential to eliminate lipid perozyl radicals, has been recently described in [https://doi.org/10.1038/s41586-022-05022-3 Nature(2022)] by Mishima et al.: A non-canonical vitamin K cycle is a potent ferroptosis suppressor.

Authors

Anna Van Wersch , Andra Waagmeester , Denise Slenter , Eric Weitz , Egon Willighagen , and Kristina Hanspers

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Disease Ontology

vitamin K deficiency bleeding

Pathway Ontology

vitamin K antagonist drug pathway vitamin and vitamin metabolites signaling pathway vitamin K metabolic pathway ferroptosis pathway hemostasis pathway classic metabolic pathway vitamin K cycle pathway lipid metabolic pathway

Cell Type Ontology

hepatocyte

Participants

Label Type Compact URI Comment
vitamin K2 Metabolite chebi:16374 AKA menaquinone, VK2
Natural vitamer
Different lengths of C-side chains in the isoprenoid group are known: MK5 ~ MK15 (produces by bacteria) [PMID:35510250]
geranylgeranyldiphosphate Metabolite chebi:58756
Vitamin K3 Metabolite chebi:28869 menadione, synthetic form of vitamin K; interferes with glutathione function.
'NQO1 competes with enzymes that redox cycle vitamin K and catalyzes two-electron reduction of vitamin K3 to hydroquinone. This skips formation of semiquinone and ROS. Therefore, NQO1 metabolically detoxifies vitamin K3 and protects cells against oxidative stress and other adverse effects.' [PMID:18374191]
This reaction has been described in more detail in a mouse study [PMID:24015818]
Vitamin K1 Metabolite chebi:18067 AKA phylloquinone, VK
Natural vitamer
Made in plants (with high concentrations in green leafy vegetables).
Converted by bacteria in gut microbiome to MK-4.
disulfides Metabolite chebi:48343
Vitamin K epoxide(VKO) Metabolite chebi:15759 AKA Vitamin K1 oxide, VKO
NADPH Metabolite hmdb:HMDB00221
gamma-carboxyglutamate Metabolite chebi:61938
dithiols Metabolite chebi:23853
Warfarin Metabolite hmdb:HMDB0001935
NADP+ Metabolite chebi:18009
Vitamin K(VK) Metabolite chebi:28384 Group of metabolites known as Vitamin K, which are structurally similar and found in food.
glutamate Metabolite chebi:14321
Menadiol Metabolite chebi:6746
Vitamin K hydroquinone(VKH2) Metabolite chebi:28433 AKA phyllohydroquinone, phylloquinol, VKH2
cofactor for the enzyme γ-glutamyl carboxylase (GGCX)
Dietary Vitamin K1 Metabolite chebi:18067
vitamin K2 (MK4) Metabolite chebi:78277 AKA menaquinone-4
vitamin K2 (MK7) Metabolite chebi:44245 AKA menaquinone-7
Vitamin K Metabolite chebi:28384 AKA phylloquinone, VK
Natural vitamer
Made in plants (with high concentrations in green leafy vegetables).
Converted by bacteria in gut microbiome to MK-4.
LOOH Metabolite wikidata:Q76617139 lipid hydroperoxides (LOOH)
UBIAD1 GeneProduct ncbigene:29914
Coagulation factor X Protein uniprot:P00742
Vitamin K-dependent protein C Protein uniprot:P04070
FSP1 Protein uniprot:Q9BRQ8
Coagulation factor VII Protein uniprot:P08709
GGCX Protein uniprot:P38435 AKA γ-glutamyl carboxylase
Vitamin K-dependent protein S Protein uniprot:P07225
Coagulation factor IX Protein uniprot:P00740
Prothrombin Protein uniprot:P00734
VKORC1 Protein uniprot:Q9BQB6 'Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K' Source: https://www.uniprot.org/uniprotkb/Q9BQB6/entry
NQO1 Protein uniprot:P15559 AKA NAD(P)H dehydrogenase [quinone] 1
Vitamin K-dependent protein Z Protein uniprot:P22891
Thrombin Protein ensembl:ENSG00000180210
VKORC1L1 Protein uniprot:Q8N0U8 'Can reduce inactive vitamin K 2,3-epoxide to active vitamin K (in vitro)' Source: https://www.uniprot.org/uniprotkb/Q8N0U8/entry
VKOR Protein eccode:1.17.4.4 Vitamin-K-epoxide reductase

References

  1. Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon? Gallieni M, Fusaro M. Kidney Int. 2014 Aug;86(2):232–4. PubMed Europe PMC Scholia
  2. Genomic Analysis of the Human Gut Microbiome Suggests Novel Enzymes Involved in Quinone Biosynthesis. Ravcheev DA, Thiele I. Front Microbiol. 2016 Feb 9;7:128. PubMed Europe PMC Scholia
  3. Effect of vitamin K in bone metabolism and vascular calcification: A review of mechanisms of action and evidences. Villa JKD, Diaz MAN, Pizziolo VR, Martino HSD. Crit Rev Food Sci Nutr. 2017 Dec 12;57(18):3959–70. PubMed Europe PMC Scholia
  4. The Relationship Among Intestinal Bacteria, Vitamin K and Response of Vitamin K Antagonist: A Review of Evidence and Potential Mechanism. Yan H, Chen Y, Zhu H, Huang WH, Cai XH, Li D, et al. Front Med (Lausanne). 2022 Apr 18;9:829304. PubMed Europe PMC Scholia
  5. Long-sought mediator of vitamin K recycling discovered. Ward NP, DeNicola GM. Nature. 2022 Aug;608(7924):673–4. PubMed Europe PMC Scholia
  6. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. Nature. 2022 Aug;608(7924):778–83. PubMed Europe PMC Scholia